These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9836048)

  • 21. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy.
    Finsterer J; Stratil U; Bittner R; Sporn P
    Can J Anaesth; 1998 Aug; 45(8):781-4. PubMed ID: 9793668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ON THE USE OF AN ANTICURARE COMBINATION IN ANESTHESIA].
    DEBONIS B
    Boll Soc Med Chir Cremona; 1963; 17():57-62. PubMed ID: 14112952
    [No Abstract]   [Full Text] [Related]  

  • 24. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The antimyorelaxant effect of cholinopotentiating drugs].
    Prozorovskiĭ VB; Vladeeva NV; Khromova ON; Dubovitskaia SI
    Biull Eksp Biol Med; 1970 Jun; 69(6):51-4. PubMed ID: 4248601
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atracurium-like decomposition of remifentanil.
    Alston TA
    J Clin Anesth; 2010 Feb; 22(1):72-3. PubMed ID: 20206858
    [No Abstract]   [Full Text] [Related]  

  • 28. Hofmann, Schmofmann: atracurium undergoes Michael elimination.
    Alston TA
    Anesthesiology; 2001 Jul; 95(1):273. PubMed ID: 11465576
    [No Abstract]   [Full Text] [Related]  

  • 29. Physical incompatibility between atracurium and intravenous diclofenac.
    Ackland G
    Anaesthesia; 2001 Mar; 56(3):294. PubMed ID: 11251469
    [No Abstract]   [Full Text] [Related]  

  • 30. Asthenic syndrome. Anticholinesterase tolerance in nonmyasthenic patients.
    MCQUILLEN MP; JONES RJ
    Arch Neurol; 1963 Apr; 8():382-7. PubMed ID: 13932274
    [No Abstract]   [Full Text] [Related]  

  • 31. Controversy over generic substitution.
    Emery J; McKenzie A; Bulsara C; Holman D
    BMJ; 2010 Jul; 341():c3570. PubMed ID: 20610498
    [No Abstract]   [Full Text] [Related]  

  • 32. More painful spikes.
    Stranix ND; Patel A
    Anaesthesia; 2000 Apr; 55(4):412. PubMed ID: 10781172
    [No Abstract]   [Full Text] [Related]  

  • 33. [More or less generic substitution/ordination?].
    Waldorff S
    Ugeskr Laeger; 2012 Jan; 174(1-2):73. PubMed ID: 22334895
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of cholinesterase; pharmacological activity of a specific inhibitor of true cholinesterase: CT-3318].
    ZANDA CE
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1445-7. PubMed ID: 13446082
    [No Abstract]   [Full Text] [Related]  

  • 35. Waiting for generic propofol.
    Tan TK
    Anaesthesia; 1999 Aug; 54(8):819. PubMed ID: 10460547
    [No Abstract]   [Full Text] [Related]  

  • 36. Packaging of generic diclofenac (corrected from diclofeanc) suppositories.
    Kitsberg A; Belavadi P
    Anaesthesia; 2004 Feb; 59(2):197-8; discussion 198. PubMed ID: 14725537
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug therapy for older people with functional impairments].
    Steinsvoll PS
    Tidsskr Nor Laegeforen; 2017 Jan; 137(1):10. PubMed ID: 28073219
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of cholinesterase inhibition by in vitro manifestation of various effects of a specific inhibitor, bis(2,3-dihydro-2-piperidinomethy1-5-benzofuranyl) ketone dimethiodide (CT-3318)].
    ZANDA CE
    Arch Int Pharmacodyn Ther; 1959 May; 120(1):53-63. PubMed ID: 13662037
    [No Abstract]   [Full Text] [Related]  

  • 39. An investigation of the structure-activity correlations within a series of ambenonium analogs.
    LANDS AM; HOPPE JO; ARNOLD A; KIRCHNER FK
    J Pharmacol Exp Ther; 1958 Jun; 123(2):121-7. PubMed ID: 13550066
    [No Abstract]   [Full Text] [Related]  

  • 40. [UBREDTID AND CONSTIPATION, CAPACITY AND TONICITY OF THE COLON UNDER THE INFLUENCE OF A CHOLINESTERASE INHIBITOR].
    DEIMER E; PARTILLA H
    Wien Klin Wochenschr; 1963 Dec; 75():927-9. PubMed ID: 14108933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.